Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Teva
Accenture
Citi
Cerilliant
Baxter
Cantor Fitzgerald
McKesson
Healthtrust
Federal Trade Commission

Generated: February 22, 2018

DrugPatentWatch Database Preview

Anidulafungin - Generic Drug Details

« Back to Dashboard

What are the generic sources for anidulafungin and what is the scope of anidulafungin patent protection?

Anidulafungin
is the generic ingredient in one branded drug marketed by Vicuron and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Anidulafungin has sixty-seven patent family members in twenty-nine countries.

There is one drug master file entry for anidulafungin. One supplier is listed for this compound.
Summary for anidulafungin
Pharmacology for anidulafungin
Ingredient-typeLipopeptides
Drug ClassEchinocandin Antifungal

US Patents and Regulatory Information for anidulafungin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-002 Nov 14, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-001 Feb 17, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-002 Nov 14, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-001 Feb 17, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-002 Nov 14, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-001 Feb 17, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for anidulafungin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-001 Feb 17, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-002 Nov 14, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-002 Nov 14, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Vicuron ERAXIS anidulafungin INJECTABLE;IV (INFUSION) 021632-001 Feb 17, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for anidulafungin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,932,543 Cyclic peptide antifungal agents and process for preparation thereof ➤ Try a Free Trial
6,916,784 Cyclic peptide antifungal agents and process for preparation thereof ➤ Try a Free Trial
7,790,744 Cyclic peptide antifungal agents and process for preparation thereof ➤ Try a Free Trial
6,384,013 Cyclic peptide antifungal agents and process for preparation thereof ➤ Try a Free Trial
6,743,777 Cyclic peptide antifungal agents and process for preparation thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for anidulafungin

Supplementary Protection Certificates for anidulafungin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C002/2008 Ireland ➤ Try a Free Trial SPC002/2008: 20081105, EXPIRES: 20180317
406 Luxembourg ➤ Try a Free Trial 91406, EXPIRES: 20180318
00334 Netherlands ➤ Try a Free Trial PRODUCT NAME: ANIDULAFUNGIN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/07/416/001 20070920
C/GB08/016 United Kingdom ➤ Try a Free Trial PRODUCT NAME: ANIDULAFUNGIN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/07/416/001 20070920
0561639/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: ANIDULAFUNGIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58325 03.09.2009
2008 00017 Denmark ➤ Try a Free Trial
C0009 France ➤ Try a Free Trial PRODUCT NAME: ANIDULAFUNGINE; REGISTRATION NO/DATE: EU/1/07/416/001 20070920
0334 Netherlands ➤ Try a Free Trial 300334, 20130318, EXPIRES: 20180317
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Merck
Mallinckrodt
UBS
Healthtrust
McKinsey
Queensland Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot